20 completed, 6 unknown, 3 recruiting, 2 not yet recruiting. 9 Phase 4, 5 Not applicable, 3 Phase 1, 3 Phase 2, 2 Phase 3.
Follow Hepatitis E: new trials by email Literature Review of Hepatitis E trials Research Report on Hepatitis E
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AT-587 in Healthy Subjects AT-587, Placebo - Hepatitis E | Phase 1 | Recruiting | Atea Pharmaceuticals, Inc. | 62 | 2026-07-13 | 2026-07-27 |
| Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis Ursodeoxycholic Acid, Supportive Care - Hepatitis A, Hepatitis E Virus Infection | Not applicable | Not yet recruiting | Combined Military Hospital, Pakistan | 88 | 2026-04-01 | 2026-04-13 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases Peripheral venous blood sample - Leishmaniasis, Leptospirosis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 183 | 2025-03-03 | 2025-03-05 |
| Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children Hecolin® Recombinant Hepatitis E Vaccine, Isotonic Sodium Chloride injection - Hepatitis E Virus Infection | Phase 2 | Recruiting | International Vaccine Institute | 1040 | 2024-04-04 | 2025-04-29 |
| Exposure to Hepatitis E Virus in Occitania, France questionnaire - Hepatitis E | Unknown | University Hospital, Toulouse | 5000 | 2023-12-15 | 2024-05-16 | |
| Long-term Effectiveness of a Recombinant Hepatitis E Vaccine serology and virology detection of hepatitis E virus - Hepatitis E | Unknown | Xiamen University | 2900 | 2023-08-12 | 2023-08-15 | |
| Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above Thiomersal-free Recombinant Hepatitis E Vaccine (Escherichia Coli), Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 612 | 2023-03-22 | 2024-08-21 |
| Seroprevalence of Leptospirosis in Val Müstair, Switzerland Blood sample collection, Data collection - Leptospirosis, Hepatitis E Virus Infection | Completed | University Hospital, Basel, Switzerland | 258 | 2022-03-03 | 2024-12-13 | |
| Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors Elecsys Anti-HEV IgG, IgM - Hepatitis E | Not applicable | Unknown | University Hospital Ostrava | 300 | 2022-01-01 | 2024-06-13 |
| Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin Cecolin, Hecolin - Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18 | Phase 4 | Unknown | Xiamen Innovax Biotech Co., Ltd | 480 | 2021-10-25 | 2022-06-13 |
| Safety Study of Hepatitis E Vaccine (HEV239) HEV 239, Placebo - Hepatitis E, Immunisation | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2019-04-12 | 2021-09-24 |
| Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies Liver and Kidney transplanted patients - Hepatitis E | Not applicable | Completed | Centre Hospitalier Universitaire de la Guadeloupe | 95 | 2019-03-22 | 2026-07-27 |
| A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month. - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 360 | 2018-10-27 | 2020-05-07 |
| HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver serum samples for HEV RNA PCR - Hepatitis E | Unknown | Mahmoud Abdel Rahman | 150 | 2018-10-01 | 2018-07-24 | |
| Seroprevalence Hepatitis E Infection in Healthy Blood Donors Sample collection - Hepatitis E | Completed | Ente Ospedaliero Cantonale, Bellinzona | 1447 | 2018-05-29 | 2020-03-31 | |
| HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) Sofosbuvir - Hepatitis E, Hepatitis Chronic Viral | Phase 2 | Completed | Hannover Medical School | 10 | 2017-12-07 | 2019-03-08 |
| A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 125 | 2017-05-25 | 2019-02-21 |
| A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 475 | 2016-08-01 | 2019-07-25 |
| Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb) HIV, Hepatitis E | Completed | Centre Hospitalier de la côte Basque | 307 | 2016-07-01 | 2018-07-17 |
Showing 20 of 32. Sign in to see all of them.
Leptospirosis (3) · Brucellosis (2) · Chikungunya Fever (2) · Encephalitis, Tick-Borne (2) · Hepatitis A (2) · Leishmaniasis (2) · Q Fever (2) · Tularemia (2) · Whooping Cough (2) · Zika Virus Infection (2) · Adenoviridae Infections (1) · Arenaviridae Infections (1) · Bunyaviridae Infections (1) · Caliciviridae Infections (1)
Digestive System Diseases (32) · Hepatitis, Viral, Human (32) · Infections (32) · Liver Diseases (32) · RNA Virus Infections (32) · Virus Diseases (32) · Hepatitis (31) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Negative Bacterial Infections (4) · Respiratory Tract Diseases (3) · Spirochaetales Infections (3) · Tick-Borne Diseases (3) · Alphavirus Infections (2) · Arbovirus Infections (2)
hecolin (7) · Sodium Chloride (2) · Data Collection (1) · Hepatitis B Vaccines (1) · Influenza Vaccines (1) · Liver Extracts (1) · Palliative Care (1) · Ribavirin (1) · Sofosbuvir (1) · Specimen Handling (1) · Surveys and Questionnaires (1) · Ursodeoxycholic Acid (1) · vaxigrip (1)
Xiamen Innovax Biotech Co., Ltd (7) · Xiamen University (3) · Atea Pharmaceuticals, Inc. (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Centre Hospitalier de la côte Basque (1) · Children's Hospital Medical Center, Cincinnati (1) · Combined Military Hospital, Pakistan (1) · Ente Ospedaliero Cantonale, Bellinzona (1) · Hannover Medical School (1) · Hospices Civils de Lyon (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Institut Pasteur du Cambodge (1) · International Vaccine Institute (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Jun Zhang (1)
China (11) · France (4) · Nepal (2) · Switzerland (2) · United States (2) · Belgium (1) · Cambodia (1) · Czechia (1) · Germany (1) · Guadeloupe (1) · South Africa (1) · Spain (1)
Zhiping Chen (2) · Aiqiang Xu (1) · Claude Flamand, Ph.D. (1) · Dongjuan Zhang (1) · Enas A Reda, professor (1) · Essack Mitha (1) · Feng-Cai Zhu, M.D. (1) · Florian Bihl, MD (1) · Jacques Izopet, MD (1) · Jianjun Niu, M.Sc. (1) · Jun Zhang, M.D. (1)
PMID 17329696, PMID 20728932, PMID 22161542, PMID 23887167, PMID 24118636, PMID 24498033, PMID 25738667, PMID 25879974, PMID 26126668, PMID 28522338, PMID 28984909, PMID 29100709, PMID 29443825, PMID 29452372, PMID 30711651, PMID 31024978, PMID 31056697, PMID 31262585, PMID 32379201, PMID 32526188, PMID 32624195, PMID 32943001, PMID 36075495, PMID 37334496, PMID 38387470, PMID 38536442, PMID 40575997, PMID 40690851, PMID 41276263, PMID 41545967, PMID 42414915
2017 (1)